372 related articles for article (PubMed ID: 34576214)
1. Glucocorticoid Resistance: Interference between the Glucocorticoid Receptor and the MAPK Signalling Pathways.
Sevilla LM; Jiménez-Panizo A; Alegre-Martí A; Estébanez-Perpiñá E; Caelles C; Pérez P
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576214
[TBL] [Abstract][Full Text] [Related]
2. Homeostatic Regulation of Glucocorticoid Receptor Activity by Hypoxia-Inducible Factor 1: From Physiology to Clinic.
Marchi D; van Eeden FJM
Cells; 2021 Dec; 10(12):. PubMed ID: 34943949
[TBL] [Abstract][Full Text] [Related]
3. Roles of the Glucocorticoid and Mineralocorticoid Receptors in Skin Pathophysiology.
Sevilla LM; Pérez P
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966221
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of Glucocorticoid Signaling.
Vitellius G; Trabado S; Bouligand J; Delemer B; Lombès M
Ann Endocrinol (Paris); 2018 Jun; 79(3):98-106. PubMed ID: 29685454
[TBL] [Abstract][Full Text] [Related]
5. Acquired Glucocorticoid Resistance Due to Homologous Glucocorticoid Receptor Downregulation: A Modern Look at an Age-Old Problem.
Spies LL; Verhoog NJD; Louw A
Cells; 2021 Sep; 10(10):. PubMed ID: 34685511
[TBL] [Abstract][Full Text] [Related]
6. p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.
Miller AL; Webb MS; Copik AJ; Wang Y; Johnson BH; Kumar R; Thompson EB
Mol Endocrinol; 2005 Jun; 19(6):1569-83. PubMed ID: 15817653
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways.
Ayroldi E; Cannarile L; Migliorati G; Nocentini G; Delfino DV; Riccardi C
FASEB J; 2012 Dec; 26(12):4805-20. PubMed ID: 22954589
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in glucocorticoid resistance.
Yang N; Ray DW; Matthews LC
Steroids; 2012 Sep; 77(11):1041-9. PubMed ID: 22728894
[TBL] [Abstract][Full Text] [Related]
9. Exploring the molecular mechanisms of glucocorticoid receptor action from sensitivity to resistance.
Ramamoorthy S; Cidlowski JA
Endocr Dev; 2013; 24():41-56. PubMed ID: 23392094
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.
Beck IM; Vanden Berghe W; Vermeulen L; Yamamoto KR; Haegeman G; De Bosscher K
Endocr Rev; 2009 Dec; 30(7):830-82. PubMed ID: 19890091
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
[TBL] [Abstract][Full Text] [Related]
12. Emerging roles of glucocorticoid receptor phosphorylation in modulating glucocorticoid hormone action in health and disease.
Galliher-Beckley AJ; Cidlowski JA
IUBMB Life; 2009 Oct; 61(10):979-86. PubMed ID: 19787703
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor in stromal cells is essential for glucocorticoid-mediated suppression of inflammation in arthritis.
Koenen M; Culemann S; Vettorazzi S; Caratti G; Frappart L; Baum W; Krönke G; Baschant U; Tuckermann JP
Ann Rheum Dis; 2018 Nov; 77(11):1610-1618. PubMed ID: 29997111
[TBL] [Abstract][Full Text] [Related]
14. Serum cholesterol selectively regulates glucocorticoid sensitivity through activation of JNK.
Yang N; Caratti G; Ince LM; Poolman TM; Trebble PJ; Holt CM; Ray DW; Matthews LC
J Endocrinol; 2014 Nov; 223(2):155-66. PubMed ID: 25161081
[TBL] [Abstract][Full Text] [Related]
15. A General Introduction to Glucocorticoid Biology.
Timmermans S; Souffriau J; Libert C
Front Immunol; 2019; 10():1545. PubMed ID: 31333672
[TBL] [Abstract][Full Text] [Related]
16. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.
Hapgood JP; Avenant C; Moliki JM
Pharmacol Ther; 2016 Sep; 165():93-113. PubMed ID: 27288728
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid receptor signaling in the eye.
Sulaiman RS; Kadmiel M; Cidlowski JA
Steroids; 2018 May; 133():60-66. PubMed ID: 29129720
[TBL] [Abstract][Full Text] [Related]
19. Non-genomic effect of glucocorticoids on cardiovascular system.
Lee SR; Kim HK; Youm JB; Dizon LA; Song IS; Jeong SH; Seo DY; Ko KS; Rhee BD; Kim N; Han J
Pflugers Arch; 2012 Dec; 464(6):549-59. PubMed ID: 23001133
[TBL] [Abstract][Full Text] [Related]
20. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
He L; Li D; Hou KZ; Liu YP
Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
